During the past decade, Spokane Joint Replacement Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spokane Joint Replacement Center" #1 sponsor was "Spokane Joint Replacement Center" with 4 trials, followed by "David F. Scott, MD" with 2 trials sponsored, "Medacta USA" with 2 trials sponsored, "MicroPort Orthopedics Inc." with 1 trials sponsored and "Pacira CryoTech, Inc., a wholly owned subsidiary of Pacira BioSciences, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spokane Joint Replacement Center" #1 collaborator was "Medacta USA" with 1 trials as a collaborator, "Orthopaedic Specialty Clinic of Spokane, PLLC" with 1 trials as a collaborator and "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Spokane Joint Replacement Center" are "Osteoarthritis, Hip" (4 trials), "Osteoarthritis, Knee" (4 trials), "Osteoarthritis" (3 trials), "Joint Disease" (2 trials) and "Knee Osteoarthritis" (2 trials). Many other conditions were trialed in "Spokane Joint Replacement Center" in a lesser frequency.

Most popular intervention types in "Spokane Joint Replacement Center" are "Device" (10 trials), "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Celecoxib" (1 trials), "Diclofenac" (1 trials), "Fasinumab" (1 trials), "Femoral Component:Medacta Masterloc Stem and Medacta MPACT cup." (1 trials) and "Hip Resurfacing" (1 trials). Other intervention names were less common.

The vast majority of trials in "Spokane Joint Replacement Center" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Spokane Joint Replacement Center". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Spokane Joint Replacement Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Spokane Joint Replacement Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".